Controversies in ANCA testing

Cleveland Clinic Journal of Medicine

Volumn 79, Issue SUPPL.3, 2012, Pages 7-11

  Specks, Ulrich ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873729888     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.79.s3.02     Document Type: Article

References (17)

1. Russell KA, Wiegert E, Schroeder DR, Homburger HA, Specks U. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions. Clin Immunol 2002; 103:196-203.
2. Langford CA. The diagnostic utility of c-ANCA in Wegener's granulomatosis. Cleve Clin J Med 1998; 65:135-140.
3. Trimarchi M, Gregorini G, Facchetti F, et al. Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine 2001; 80:391-404.
4. Wiesner O, Russell KA, Lee AS, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 2004; 50:2954-2965.
5. Peikert T, Finkielman JD, Hummel AM, et al. Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions. Arthritis Rheum 2008; 58:1546-1551.
6. Knowles L, Buxton JA, Skuridina N, et al. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J 2009; 6 (Nov 17):30. doi:10.1186/1477-7517-6-30.
7. Zhu NY, LeGatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009; 150:287-289.
8. Bradford M, Rosenberg B, Moreno J, Dumyati G. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 2010; 152:758-759.
9. Waller JM, Feramisco JD, Alberta-Wszolek L, McCalmont TH, Fox LP. Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit [published online ahead of print March 20, 2010]? J Am Acad Dermatol 2010; 63:530-535. doi: 10.1016/j. jaad.2010.01.055
10. Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant [published online ahead of print July 28, 2010]. Clin Pharmacol Ther
11. Finkielman JD, Merkel PA, Schroeder D, et al. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med 2007; 147:611-619.
12. Cartin-Ceba R, Golbin J, Keogh KA, et al. Rituximab for remission induction and maintenance in granulomatosis with polyangiitis (Wegener's): a single-center ten-year experience [published online ahead of print June 21, 2012]. Arthritis Rheum. doi: 10.1002/art.34584
13. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ; and the Glomerular Disease Collaborative Network. Prognostic markers in patients with antineutrophil cytoplasmic autoantibodyassociated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7:23-32.
14. Booth AD, Almond MK, Burns A, et al. Outcome of ANCAassociated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41:776-784.
15. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349:36-44.
16. Franssen CFM, Gans ROB, Arends B, et al. Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int 1995; 47:193-199.
17. Stone JH, Merkel PA, Spiera R, et al; for the RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCAassociated vasculitis. N Engl J Med 2010; 363:221-232.